1. Home
  2. APA vs ALGN Comparison

APA vs ALGN Comparison

Compare APA & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo APA Corporation

APA

APA Corporation

HOLD

Current Price

$25.88

Market Cap

8.7B

Sector

Energy

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$165.05

Market Cap

11.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APA
ALGN
Founded
1954
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Industrial Specialties
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7B
11.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
APA
ALGN
Price
$25.88
$165.05
Analyst Decision
Hold
Buy
Analyst Count
18
14
Target Price
$25.06
$188.92
AVG Volume (30 Days)
5.8M
1.6M
Earning Date
11-05-2025
02-04-2026
Dividend Yield
3.86%
N/A
EPS Growth
N/A
N/A
EPS
4.16
5.16
Revenue
$9,376,000,000.00
$3,982,622,000.00
Revenue This Year
N/A
$2.58
Revenue Next Year
N/A
$3.41
P/E Ratio
$6.24
$32.05
Revenue Growth
4.53
0.56
52 Week Low
$13.58
$122.00
52 Week High
$27.72
$241.29

Technical Indicators

Market Signals
Indicator
APA
ALGN
Relative Strength Index (RSI) 57.14 78.33
Support Level $25.86 $144.00
Resistance Level $26.66 $166.61
Average True Range (ATR) 0.83 4.66
MACD 0.02 1.60
Stochastic Oscillator 57.79 94.04

Price Performance

Historical Comparison
APA
ALGN

About APA APA Corporation

APA Corp is an independent exploration and production company. It develops, and produces crude oil, natural gas, and natural gas liquids. The Company's business has oil and gas operations in three geographic areas: the United States (U.S.), Egypt, and offshore the U.K. in the North Sea (North Sea). APA also has active development, exploration, and appraisal operations ongoing in Suriname, as well as exploration interests in Uruguay, Alaska, and other international locations.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: